These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 1683121

  • 21. Oral acyclovir and recurrent genital herpes during late pregnancy.
    Haddad J, Langer B, Astruc D, Messer J, Lokiec F.
    Obstet Gynecol; 1993 Jul; 82(1):102-4. PubMed ID: 8390630
    [Abstract] [Full Text] [Related]

  • 22. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
    Schmit I, Boivin G.
    J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
    [Abstract] [Full Text] [Related]

  • 23. Treatment of genital herpes.
    Stone KM, Whittington WL.
    Rev Infect Dis; 1990 Aug; 12 Suppl 6():S610-9. PubMed ID: 2166968
    [Abstract] [Full Text] [Related]

  • 24. Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient.
    Kost RG, Hill EL, Tigges M, Straus SE.
    N Engl J Med; 1993 Dec 09; 329(24):1777-82. PubMed ID: 8232486
    [No Abstract] [Full Text] [Related]

  • 25. Topical treatment of infection with acyclovir-resistant mucocutaneous herpes simplex virus with the ribonucleotide reductase inhibitor 348U87 in combination with acyclovir.
    Safrin S, Schacker T, Delehanty J, Hill E, Corey L.
    Antimicrob Agents Chemother; 1993 May 09; 37(5):975-9. PubMed ID: 8390815
    [Abstract] [Full Text] [Related]

  • 26. Acyclovir for genital herpes simplex virus infections. A review.
    Baker DA, Milch PO.
    J Reprod Med; 1986 May 09; 31(5 Suppl):433-8. PubMed ID: 3522895
    [Abstract] [Full Text] [Related]

  • 27. Genital herpes simplex infections in patients with the acquired immunodeficiency syndrome.
    McGrath BJ, Newman CL.
    Pharmacotherapy; 1994 May 09; 14(5):529-42. PubMed ID: 7997387
    [Abstract] [Full Text] [Related]

  • 28. Double-blind comparison of weekend and daily regimens of oral acyclovir for suppression of recurrent genital herpes.
    Straus SE, Seidlin M, Takiff HE, Rooney JF, Lehrman SN, Bachrach S, Felser JM, Di Giovanna JJ, Grimes GJ, Krakauer H.
    Antiviral Res; 1986 May 09; 6(3):151-9. PubMed ID: 3015019
    [Abstract] [Full Text] [Related]

  • 29. Susceptibility to acyclovir of herpes simplex virus isolates obtained between 1977 and 1996 in Japan.
    Hasegawa T, Kawana T, Okuda T, Horii M, Tsukada T, Shiraki K.
    J Med Virol; 2001 Jan 09; 63(1):57-63. PubMed ID: 11130888
    [Abstract] [Full Text] [Related]

  • 30. In vitro acyclovir sensitivity of herpes simplex viruses isolated from female genital herpes in Japan.
    Hashido M, Kawana T.
    Kansenshogaku Zasshi; 1988 Feb 09; 62(2):141-6. PubMed ID: 2842414
    [No Abstract] [Full Text] [Related]

  • 31. A point mutation in the thymidine kinase gene is responsible for acyclovir-resistance in herpes simplex virus type 2 sequential isolates.
    Palù G, Gerna G, Bevilacqua F, Marcello A.
    Virus Res; 1992 Sep 01; 25(1-2):133-44. PubMed ID: 1329374
    [Abstract] [Full Text] [Related]

  • 32. Therapeutical effects of intravenous acyclovir administration in patients affected with genital herpes.
    Corbino N, Guglielmino S, Ciravolo L, Tempera G.
    Chemioterapia; 1987 Jun 01; 6(2 Suppl):667-70. PubMed ID: 2855617
    [No Abstract] [Full Text] [Related]

  • 33. Mucocutaneous dissemination of acyclovir-resistant herpes simplex virus in a patient with AIDS.
    Marks GL, Nolan PE, Erlich KS, Ellis MN.
    Rev Infect Dis; 1989 Jun 01; 11(3):474-6. PubMed ID: 2546244
    [Abstract] [Full Text] [Related]

  • 34. [Acyclovir-resistant herpes simplex virus].
    Aukrust P.
    Tidsskr Nor Laegeforen; 1990 Sep 10; 110(21):2770-3. PubMed ID: 2171155
    [Abstract] [Full Text] [Related]

  • 35. Asymptomatic herpes simplex virus shedding from the genital tract whilst on suppressive doses of oral acyclovir.
    Bowman CA, Woolley PD, Herman S, Clarke J, Kinghorn GR.
    Int J STD AIDS; 1990 May 10; 1(3):174-7. PubMed ID: 1964599
    [Abstract] [Full Text] [Related]

  • 36. Effect of long-term, low-dose acyclovir suppressive therapy on susceptibility to acyclovir and frequency of acyclovir resistance of herpes simplex virus type 2.
    Honda M, Okuda T, Hasegawa T, Kurokawa M, Shiraki K, Matsuo K, Komatsuzaki M, Niimura M.
    Antivir Chem Chemother; 2001 Jul 10; 12(4):233-9. PubMed ID: 11771732
    [Abstract] [Full Text] [Related]

  • 37. Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials.
    Sarisky RT, Bacon TH, Boon RJ, Duffy KE, Esser KM, Leary J, Locke LA, Nguyen TT, Quail MR, Saltzman R.
    Arch Virol; 2003 Sep 10; 148(9):1757-69. PubMed ID: 14505088
    [Abstract] [Full Text] [Related]

  • 38. Extended acyclovir therapy for herpes genitalis: changes in virus sensitivity and strain variation.
    Lehrman SN, Hill EL, Rooney JF, Ellis MN, Barry DW, Straus SE.
    J Antimicrob Chemother; 1986 Oct 10; 18 Suppl B():85-94. PubMed ID: 3025158
    [Abstract] [Full Text] [Related]

  • 39. In vitro and in vivo evaluation of a novel antiherpetic flavonoid, 4'-phenylflavone, and its synergistic actions with acyclovir.
    Hayashi K, Iinuma M, Sasaki K, Hayashi T.
    Arch Virol; 2012 Aug 10; 157(8):1489-98. PubMed ID: 22580497
    [Abstract] [Full Text] [Related]

  • 40. Susceptibility to acyclovir of herpes simplex virus: emergence of resistance in patients with lymphoid and myeloid neoplasia.
    Gray JJ, Wreghitt TG, Baglin TP.
    J Infect; 1989 Jul 10; 19(1):31-40. PubMed ID: 2550557
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.